R&D Systems Inc. Tocris Bioscience Boston Biochem

Non-selective Metabotropic Glutamate

Agonists
Cat.No.
Product Name / Activity
0216 L-Cysteinesulfinic acid
mGlu and NMDA agonist
0217 D-Glutamic acid
Endogenous, non-selective agonist. Less active enantiomer
0218 L-Glutamic acid
Endogenous, non-selective agonist
0285 Ibotenic acid
Non-selective mGlu agonist, also NMDA agonist
Antagonists
Cat.No.
Product Name / Activity
1112 ACPT-II
Competitive mGlu receptor antagonist
3699 DL-AP4 Sodium salt
Broad spectrum EAA antagonist
0102 D-AP4
Broad spectrum EAA antagonist. Less potent enantiomer
0101 DL-AP4
Broad spectrum EAA antagonist
0112 γDGG
Broad spectrum glutamate receptor antagonist
0223 Kynurenic acid
Broad spectrum EAA antagonist
Other
Cat.No.
Product Name / Activity
0310 (RS)-4-Carboxy-3-hydroxyphenylglycine
Broad spectrum EAA ligand
0321 (RS)-4-Carboxyphenylglycine
Broad spectrum EAA ligand
1490 MNI-caged-L-glutamate
Stable photoreleaser of L-glutamate

Quick Order

Find multiple products by catalog number

divider line

Pain Research Guide

Reserve your free copy

Pain Research Guide

Highlights over 280 products for Pain research. Reserve copy

divider line

mGlu Receptors Review

Metabotropic Glutamate Receptors Review

Written by Francine Acher, an expert in the field. Request a copy or view PDF today.

divider line

Neurobiology of Parkinson's Disease

Written by A. Schapira

Parkinson's Poster

'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

Tocris Events

Win a Kindle

event

5th Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders

June 23 - 26, 2013

Bath, UK